(Q64127429)

English

Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

based on heuristic

inferred from title

author name string

Li Guo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jianwei Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hongli Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hongli Si

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Min Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jingdong Song

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bingjuan Han

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yi Shu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Lili Ren

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jianguo Qu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Tao Hung

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

4 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

460-468

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Outbreaks of food-borne and waterborne viral gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Molecular epidemiology of human enteric caliciviruses in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Molecular Epidemiology of “Norwalk‐like Viruses” in Outbreaks of Gastroenteritis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Detection of norwalk-like virus in shellfish implicated in illness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Surveillance of small round structured virus (SRSV) infection in England and Wales, 1990-5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Detection of Norwalk virus or Norwalk-like virus infections in Finnish infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Molecular epidemiology of outbreaks of gastroenteritis associated with small round structured viruses in Germany in 1997/98.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk virus infection in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Genomic diversity of "Norwalk like viruses" (NLVs): pediatric infections in a Brazilian shantytown

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk virus vaccines: challenges and progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk virus genome cloning and characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Sequence and genomic organization of Norwalk virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

A simple and efficient method for purification of infectious recombinant adenovirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Human caliciviruses in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Prospects for vaccine protection against HIV-1 infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Cellular and humoral immunity following Snow Mountain virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

High efficiency cross-reactive monoclonal antibody production by oral immunization with recombinant norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.039

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64127429&oldid=1955722621"